| Cancer |
Tissue Repository For The Collection of Hematologic Samples |
Suzanne Lentzsch, MD |
| Cancer |
Identification of Targets for Cancer Treatment |
Andrea Califano, PhD |
| Cancer |
Study of Atezolizumab in Alveolar Soft Part Sarcoma |
Prabhjot Mundi, MD |
| Cancer |
Study of Drug in Patients with Advanced Solid Malignancies and Lymphoma |
June Hou, MD |
| Cancer |
Clinical Trial Screening Tool to Address Cancer Health Disparities |
Katherine Crew, MD |
| Cancer |
Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC) |
Mark Stein, MD |
| Cancer |
Study of IDE196 in Patients with Solid Tumors |
Alexander Wei, MD |
| Cancer |
Study of A Vaccine Targeting Shared Neoantigens in Subjects with Advanced Solid Tumors |
Brian Henick, MD |
| Cancer |
Study of Rituximab or Tocilizumab for Patients With Steroid-Dependent Immune-Related Adverse Events (irAEs) |
Brian Henick, MD |
| Cancer |
Safety Study of PBCAR0191 in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma and r/r B-cell Acute Lymphoblastic Leukemia |
Ran Reshef, MD |
| Cancer |
A Study of MORAb-202 in Participants With Selected Tumor Types |
June Hou, MD |
| Cancer |
Study of Safety and Tolerability of BCA101 Alone and in Combination With Pembrolizumab in Patients With EGFR-driven Advanced Solid Tumors |
Catherine Shu, MD |
| Cancer |
Study of ST101 in Patients with Advanced Solid Tumors |
Fabio Iwamoto, MD |
| Cancer |
Study of IMC-F106C Alone and in Combination With Checkpoint Inhibitors in Participants with Advanced Cancers |
Benjamin Izar, MD |
| Cancer |
Study of Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies |
Susan Bates, MD |
| Cancer |
A Study of BMS-986340 Alone and in Combination With Nivolumab in Participants With Advanced Solid Tumors |
Ryan Moy, MD |
| Cancer |
Study of Investigational Drug (RP-6306) in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of BAY 1895344 in Combination with Chemotherapy for Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Study of Financial Navigator Addressing Cancer-Related Financial Hardship in Cancer Patients and Their Spouses |
Dawn Hershman, MD |
| Cancer |
Study of Isatuximab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) |
Divaya Bhutani, MD |
| Cancer |
Study of RP-3500 in Combination with PARP Inhibitor for Patients with Advanced Cancer |
Benjamin Herzberg, MD |
| Cancer |
Study of IDE397 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of CS5001 in Patients with Advanced Solid Tumors |
Hua-Jay Cherng, MD |
| Cancer |
ACCESS: Study of Donor Blood Stem Cell Transplant in Patients with Multiple Myeloma, Leukemia, or Lymphoma |
Ran Reshef, MD |
| Cancer |
Study of BT7480 in Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Study of ASP3082 in Patients with Advanced Cancer with a KRAS G12D Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of STK-012 Alone or in Combination with Pembrolizumab (KEYTRUDA) in Patients with Advanced Solid Tumors |
Benjamin Izar, MD |
| Cancer |
Study of 68Ga-FAP-2286 and 177Lu-FAP-2286 in Patients with Advanced Cancer |
Ryan Moy, MD |
| Cancer |
Study of BLU-222 Alone or in Combination with Other Cancer Therapy for Patients with Advanced Cancer |
Brian Henick, MD |
| Cancer |
Study of LNS8801 Alone or in Combination with Pembrolizumab in Patients with Advanced Cancer |
Brian Henick, MD |
| Cancer |
Study of RMC-6291 in Patients with Advanced Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of XL092 Alone or in Combination with Anticancer Therapy in Patients with Unresectable orMetastatic Solid Tumors |
Karie D. Runcie, MD |
| Cancer |
Study of MRT-2359 in Patients with Solid Tumors |
Benjamin Herzberg, MD |
| Cancer |
Study of RMC-6236 in Patients with Solid Tumors with a KRAS Mutation |
Benjamin Herzberg, MD |
| Cancer |
Study of BGB-16673 in Patients with Leukemia or Lymphoma |
Nicole Lamanna, MD |
| Cancer |
Study of NDI-101150 Alone or in Combination with Pembrolizumab in Patients with Solid Tumors |
Ryan Moy, MD |
| Cancer |
Study of XmAb808 in Combination with Pembrolizumab in Patients with Advanced Cancer |
Mark Stein, MD |
| Cancer |
Cooling and Compression to Prevent Nerve Damage During Chemotherapy |
Melissa Accordino, MD |
| Cancer |
Study of T Plex in Patients with Advanced or Metastatic Solid Tumors |
Brian Henick, MD |
| Cancer |
Study of ZEN003694 (ZEN-3694) in Combination with Capecitabine in Patients with Solid Tumors |
Ryan Moy, MD |
| Cancer |
Study of HRO761 Alone or in Combination with Tislelizumab or Irinotecan in Patients with Solid Tumors |
Edmond Chan, MD |
| Cancer |
Study of CTX-009 Alone or in Combination with Paclitaxel in Patients with Cancer |
Ruth White, MD, PhD |
| Breast Cancer |
Study to Predict Your Therapeutic Response (I-SPY 2 Trial) |
Meghna Trivedi, MD |
| Breast Cancer |
Study Comparing Survival of Patients Monitored with Serum Tumor Marker Directed Disease Versus Usual Care in Metastatic Breast Cancer |
Melissa Accordino, MD |
| Breast Cancer |
Addinex-Opioid Dispenser for Post-Op Pain in Cancer Patients |
Dawn Hershman, MD |
| Breast Cancer |
Study of Symptom Monitoring using Young, Empowered & Strong (YES) Web Portal for Breast Cancer Survivors |
Dawn Hershman, MD |
| Breast Cancer |
Study of T-DM1 in Combination with Tucatinib for Patients with HER2-Positive Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Intervention to Improve Medication Scheduling for Patients with Breast Cancer |
Dawn Hershman, MD |
| Breast Cancer |
Study of RLY-2608 in Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of GLSI-100 in Female Patients with Breast Cancer |
Julia McGuinness, MD |
| Breast Cancer |
Study of Denosumab in Women with Breast Cancer who Carry the BRCA1 Mutation |
Katherine Crew, MD |
| Breast Cancer |
Study of Sacituzumab Govitecan (TRODELVY) in Patients with Triple-Negative Breast Cancer (TNBC) |
Meghna Trivedi, MD |
| Breast Cancer |
Study of Sacituzumab Govitecan in Combination with Pembrolizumab vs. Chemotherapy in Patients with Advanced Triple-Negative Breast Cancer |
Meghna Trivedi, MD |
| Breast Cancer |
Study of Breast Cancer in Black Women |
Lauren Houghton, PhD |
| Breast Cancer |
Study of Breast Cancer in Black Women - Healthy Controls |
Lauren Houghton, PhD |
| Breast Cancer |
Improving Medication Barriers Among Patients with Metastatic Breast Cancer |
Claire Sathe, MD |
| Breast Cancer |
Impact of Aromatase Inhibitors on Daily Activities for Individuals with Breast Cancer |
Rochelle Mendonca, PhD |
| Multiple Myeloma |
Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma (KarMMa-2) |
Ran Reshef, MD |
| Multiple Myeloma |
First in Human (FIH) Study of REGN5458 in Patients With Relapsed or Refractory Multiple Myeloma |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM) |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of VRd Followed by Cilta-cel vs. VRd Followed by Rd Therapy in Patients with Newly Diagnosed Multiple Myeloma |
Ran Reshef, MD |
| Multiple Myeloma |
Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of Teclistamab In Patients with Multiple Myeloma |
Divaya Bhutani, MD |
| Multiple Myeloma |
Study of REGN5458 in Patients with Multiple Myeloma |
Rajshekhar Chakraborty, MD |
| Multiple Myeloma |
Study of BMS-986393 in Patients with Multiple Myeloma (MM) |
Divaya Bhutani, MD |
| Skin Cancer |
Study of RP1 in Organ Transplant Patients with Skin Cancer |
Shaheer Khan, DO |
| Liver Cancer |
Study of Atezolizumab and Bevacizumab Alone or in Combination with Tiragolumab in Patients with Hepatocellular Carcinoma (HCC) |
Ruth White, MD, PhD |
| Lymphoma |
Study of Drug for Solid Organ Transplant Subjects with Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease |
Ran Reshef, MD |
| Lymphoma |
Study of Tazemetostat or Placebo with Lenalidomide plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of Isatuximab in Patients with Multiple Myeloma or Lymphoma who are Recovering from Stem Cell Transplant |
Divaya Bhutani, MD |
| Lymphoma |
Study of Venetoclax in Addition to Usual Treatment for Patients with Waldenstrm's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) |
Divaya Bhutani, MD |
| Lymphoma |
Study of CC-486 (Oral Azacitidine) Alone or in Combination with Chemo in Participants with Diffuse Large B Cell Lymphoma (DLBCL) (Ages 75+) |
Jennifer Amengual, MD |
| Lymphoma |
Study of TAK-007 in Patients with Non-Hodgkin Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Pembrolizumab, Ibrutinib and Rituximab in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Lymphoma |
Study of Tazemetostat in Combination with Belinostat in Patients with Relapsed or Refractory Lymphoma |
Jennifer Amengual, MD |
| Lymphoma |
Study of ONO-4685 in Patients with T-Cell Lymphoma |
Barbara Pro, MD |
| Lymphoma |
Study of Axi-cel vs. Chemotherapy in Patients with High-Risk Large B-Cell Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
| Lymphoma |
Study of KITE-363 vs. KITE-753 in Patients with B-cell Lymphoma |
Ran Reshef, MD |
| Lymphoma |
Study of Tazemetostat or Zanubrutinib for Patients with Large B-Cell Lymphoma (LBCL) |
Jennifer Amengual, MD |
| Lymphoma |
Study of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma |
Barbara Pro, MD |
| Lymphoma |
Treatment After CAR T-Cell Therapy for Patients with Diffuse Large B-cell Lymphoma (DLBCL) |
Hua-Jay Cherng, MD |
| Lung Cancer |
Study of Therapies in Participants with Resectable (removable) and Untreated Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Testing Whether the Use of Brain Scans Alone vs. Brain Scans Plus Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer |
Simon Cheng, MD, PhD |
| Lung Cancer |
Study of Osimertinib (TAGRISSOTM) in Non-Small Cell Lung Cancer (NeoADAURA) Patients |
Catherine Shu, MD |
| Lung Cancer |
ApricityCare: Smartphone App Study for Patients with Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of Savolitinib in Combination with Osimertinib vs. Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study of Osimertinib (TAGRISSOTM) in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study of JNJ-86974680 Alone or in Combination with Cetrelimab and Radiotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Brian Henick, MD |
| Lung Cancer |
Study of CLN-081 in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Catherine Shu, MD |
| Lung Cancer |
Study of Ramucirumab Plus Pembrolizumab vs. Standard of Care in Patients with Non-Small Cell Lung Cancer (NSCLC) |
Stephanie Smith-Marrone, MD |
| Gynecologic Cancer |
Study of REGN4018 Alone or in Combination with Cemiplimab in Patients with Ovarian Cancer |
June Hou, MD |
| Gynecologic Cancer |
Study of SL-172154 in Combination with PLD or MIRV in Patients with Ovarian Cancer |
June Hou, MD |
| Gynecologic Cancer |
Comparing Investigational Surgery to Laparotomy After Chemotherapy in Women with Epithelial Ovarian Cancer (EOC) |
Jason Wright, MD |
| Gynecologic Cancer |
Comparing Surgeries to Reduce the Risk of Ovarian Cancer in Women with BRCA1 Mutations |
Jason Wright, MD |
| Gynecologic Cancer |
Study of ZN-c3 in Patients with Solid Tumors with MRE11, RAD50, NBN, or CCNE1 Gene Mutations |
June Hou, MD |
| Gynecologic Cancer |
Study of TransCon IL-2 / vs. TransCon TLR7/8 Agonist in Patients with Gynecologic Cancer |
June Hou, MD |
| Pancreatic Cancer |
The Cancer of the Pancreas Screening-5 Study (CAPS5 Study) |
Fay Kastrinos, MD |
| Pancreatic Cancer |
Study of Stimulation with Bethanechol in Pancreatic Adenocarcinoma Prior to Surgery |
Susan Bates, MD |
| Pancreatic Cancer |
Chemo4METPANC: Combination of Chemotherapy, Motixafortide, and Cemiplimab in Patients with Pancreatic Cancer |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Bethanechol in Combination with Chemotherapy for Patients with Pancreatic Cancer |
Susan Bates, MD |
| Pancreatic Cancer |
Study of SBP-101 Alone or in Combination with Chemotherapy in Patients with Untreated Pancreatic Ductal Adenocarcinoma (PDAC) |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Zimberelimab in Patients with Advanced Pancreatic Cancer who are Eligible for Surgery |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of Autogene Cevumeran & Atezolizumab Alone or in Combination with mFOLFIRINOX in Patients with Resected Pancreatic Cancer (PDAC) |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of CA-4948 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Pancreatic Cancer |
Gulam Manji, MD, PhD |
| Pancreatic Cancer |
Study of ASP2138 in Patients with Stomach or Pancreatic Cancer |
Ryan Moy, MD |
| Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Leukemia |
Study of Panzyga in Primary Infection Prophylaxis (Prevention) in Patients with Chronic Lymphocytic Leukemia (PRO-SID) |
Nicole Lamanna, MD |
| Leukemia |
Study of BGB-11417 in Patients with Leukemia |
Nicole Lamanna, MD |
| Leukemia |
Study for Patients with Chronic Lymphocytic Leukemia (CLL) who are Currently Receiving Treatment with Venetoclax |
Nicole Lamanna, MD |
| Leukemia |
Study of TSC 100 & TSC 101 in Patients with Leukemia Undergoing Haploidentical Allogeneic Blood Stem Cell Transplantation (HCT) |
Ran Reshef, MD |
| Leukemia |
Study of Pirtobrutinib (LOXO-305) Alone or in Combination With Chemotherapy in Patients with Chronic Lymphocytic Leukemia (CLL) |
Nicole Lamanna, MD |
| Leukemia |
Study of Polatuzumab Vedotin in Combination with Chemotherapy in Subjectswith Richter's Transformation |
Andrew Lipsky, MD |
| Leukemia |
Study of Drug - DSP-5336 in Patients with Leukemia |
Joseph Jurcic, MD |
| Leukemia |
Study of Etavopivat in Patients with Myelodysplastic Syndromes (MDS) |
Joseph Jurcic, MD |
| Leukemia |
Study of VOR33 in Patients with Acute Myeloid Leukemia (AML) |
Markus Mapara, MD |
| Leukemia |
Study of Quizartinib in Combination with Chemotherapy for Children and Young Adults with Recurrent /Refractory Acute Myeloid Leukemia (AML) |
Luca Szalontay, MD |
| Leukemia |
Study of SEA-CD70 in Patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) |
Joseph Jurcic, MD |
| Leukemia |
Bone Marrow Transplant (BMT) Study in Patients with Acute Leukemia |
Markus Mapara, MD |
| Head and Neck Cancer |
Study of NBTRX3 in Patients with Head & Neck Squamous Cell Carcinoma (HNSCC) |
Brian Henick, MD |
| Bladder Cancer |
ADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the Bladder |
Christopher Anderson, MD |
| Bladder Cancer |
Study of Gemcitabine and Docetaxel Treatment in Patients with Bladder Cancer (BRIDGE) |
Andrew Lenis, MD |
| Gastrointestinal |
Study of Domvanalimab and Zimberelimab Alone or in Combination with Chemotherapy in Patients with Upper Gastrointestinal Cancers (UGI) |
Ryan Moy, MD |
| Gastrointestinal |
Study of DKN-01 in Combination with Tislelizumab & Chemotherapy in Patients with Advanced Gastric or Gastroesophageal Junction (GEJ) Cancer |
Ryan Moy, MD |
| Gastrointestinal |
Study of ASP2138 in Patients with Stomach or Pancreatic Cancer |
Ryan Moy, MD |
| Prostate Cancer |
IRONMAN: International Registry for Men with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of XmAb20717 Alone or in Combination with Chemotherapy in Patients with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of CC-94676 in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of JNJ-78278343 in Patients with Advanced Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Whole-Food Plant-Based Diet (WFPBD) to Control Weight in Overweight/Obese Men with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of VTP-850 in Male Patients with Prostate Cancer Whose Prostate-Specific Antigen (PSA) Levels Have Risen |
Mark Stein, MD |
| Prostate Cancer |
Study of JNJ-87189401 in Combination with JNJ 78278343 in Patients with Prostate Cancer |
Mark Stein, MD |
| Prostate Cancer |
Study of Apalutamide Alone or in Combination with ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) |
Karie D. Runcie, MD |
| Prostate Cancer |
Study of ONC-392 in Combination with PLUVICTO in Male Patients with Prostate Cancer |
Mark Stein, MD |
| Kidney Cancer |
Study of Spartalizumab and Canakinumab Prior to Radical Nephrectomy in Patients with Localized Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Kidney Cancer |
Cyto-KIK Trial: CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition |
Mark Stein, MD |
| Kidney Cancer |
Study of XmAb819 in Patients with Clear Cell Renal Cell Carcinoma |
Karie D. Runcie, MD |
| Sarcoma |
A Study of AL102 in Patients With Progressing Desmoid Tumors (RINGSIDE) |
Prabhjot Mundi, MD |
| Sarcoma |
Study of AGEN1181 Alone or in Combination with Balstilimab in Patients with Advanced Sarcoma |
Brian Henick, MD |
| Uveal Melanoma |
A Prospective Natural History Study in Uveal Melanoma |
Mariam El-Ashmawy, MD, PhD |
| Brain Cancer |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Brain Cancer |
Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma |
Mary Welch, MD |
| Brain Cancer |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of Vaccine for Cytomegalovirus (CMV) in Patients with Brain Tumors |
Andrew Lassman, MD |
| Brain Cancer |
Study of Focused Ultrasound (FUS) with DEFINITY Microbubbles in Children and Young Adults with Progressive Diffuse Midline Glioma (DMG) |
Cheng-Chia Wu, MD |
| Brain Cancer |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of DSP-0390 in Patients with Recurrent High-Grade Glioma |
Mary Welch, MD |
| Brain Cancer |
Study of Safusidenib in Patients with Brain Glioma |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of ONC201 After Radiation in Patients with Glioma |
Aya Haggiagi, MD |
| Brain Cancer |
Study of REC-2282 in Patients with Progressive NF2 Mutated Meningiomas |
Fabio Iwamoto, MD |
| Brain Cancer |
Study of PF-07799544 in Patients with Solid Brain Tumors |
Aya Haggiagi, MD |
| Brain Cancer |
Study of Radiosurgery & Nivolumab Alone or in Combination with Ipilimumab in Patients with Meningioma |
Aya Haggiagi, MD |
| Brain Tumors |
Study to Evaluate Multiple Treatments for Patients with Newly Diagnosed or Recurrent GBM |
Andrew Lassman, MD |
| Childhood Leukemia |
Study of Nivolumab in Combination with 5-Azacytidine in Acute Myeloid Leukemia (AML) - Children and Adults Age 1 to 30 |
Nobuko Hijiya, MD |
| Melanoma |
Study of SD-101 in Patients with Metastatic Uveal Melanoma (Eye Cancer) with Liver Disease |
Alexander Wei, MD |
| Brain Tumors |
Study of Vismodegib and GSK2256098 to Shrink Tumors in Patients with Meningioma |
Mary Welch, MD |
| Brain Tumors |
Study of Chemotherapy Drug, Lomustine, in Addition to Temozolomide in Patients with Glioblastoma (GBM) |
Fabio Iwamoto, MD |
| Brain Tumors |
Study of Immune Therapy Drugs in Addition to the Usual Radiation Therapy for Patients with Brain Cancer (Glioblastoma) |
Fabio Iwamoto, MD |
| Melanoma |
Study of DYP688 in Patients with Melanoma |
Alexander Wei, MD |
| Healthy Volunteers |
Columbia University Biobank at New York Presbyterian (CUB-NYP) |
Muredach Reilly, MD |
| Brain Tumors |
Study of Tirabrutinib in Patients with Primary Central Nervous System Lymphoma (PCNSL) |
Fabio Iwamoto, MD |
| Brain Tumors |
Study of DSP-0390 in Patients with Recurrent High-Grade Glioma |
Mary Welch, MD |
| Melanoma |
Study of Fianlimab and Cemiplimab vs. Pembrolizumab in Patients with Resected High-Risk Melanoma |
Benjamin Izar, MD |
| Cancer |
Study of Relatlimab and Nivolumab in Patients Under 30 Years Old with Classical Hodgkin Lymphoma (cHL) and Non-Hodgkin Lymphoma (NHL) |
Nobuko Hijiya, MD |
| Brain Tumors |
Study of PF-07799544 in Patients with Solid Brain Tumors |
Aya Haggiagi, MD |
| Heart Disease |
The DREAM Sleep Health Clinical Trial |
Nour Makarem, PhD |
| Childhood Leukemia |
PEPN2113: Study of Uproleselan in Children with AML, MDS, or MPAL |
Luca Szalontay, MD |
| Diabetes |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Healthy Volunteers |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
| Obesity |
Temporary Insulin Resistance |
Joshua Cook, MD, PhD |
